총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Regeneron Pharmaceuticals, Inc. (REGN), 포함 23 건 매수 및 27 건 매도. 내부자 매수 총액은 $11.7M 내부자 매도 총액은 $156.61M.
최근 활동이 있는 주요 내부자에는 Ryan Arthur F, Zoghbi Huda Y, Pitofsky Jason. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — REGN
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2026-04-01 |
Ryan Arthur F |
Director |
정보 매도 |
40 |
$779.71 |
$31.19K |
17,603 |
| 2026-03-02 |
Ryan Arthur F |
Director |
정보 매도 |
20 |
$789.28 |
$15.79K |
17,703 |
| 2026-02-19 |
Zoghbi Huda Y |
Director |
옵션 행사 (매도) |
1,638 |
$376.69 |
$617.02K |
800 |
| 2026-02-09 |
Ryan Arthur F |
Director |
정보 매도 |
1 |
$787.82 |
$787.82 |
17,803 |
| 2026-02-09 |
Pitofsky Jason |
SVP Controller |
옵션 행사 (매도) |
1,000 |
$492.00 |
$492K |
905 |
| 2026-01-07 |
Bassler Bonnie L |
Director |
정보 매도 |
1,500 |
$800.00 |
$1.2M |
1,703 |
| 2026-01-02 |
Brown Michael S |
Director |
RSU 부여 |
155 |
- |
- |
1,703 |
| 2026-01-02 |
Ryan Arthur F |
Director |
RSU 부여 |
1,962 |
$772.76 |
$1.52M |
1,962 |
| 2026-01-02 |
Poon Christine A |
Director |
RSU 부여 |
1,962 |
$772.76 |
$1.52M |
1,962 |
| 2026-01-02 |
Coles N Anthony |
Director |
RSU 부여 |
155 |
- |
- |
1,714 |
| 2026-01-02 |
Sing George L |
Director |
RSU 부여 |
1,962 |
$772.76 |
$1.52M |
1,962 |
| 2026-01-02 |
Goldstein Joseph L |
Director |
RSU 부여 |
1,962 |
$772.76 |
$1.52M |
1,962 |
| 2026-01-02 |
Thompson Craig B. |
Director |
RSU 부여 |
155 |
- |
- |
775 |
| 2026-01-02 |
Schenkein David P |
Director |
RSU 부여 |
155 |
- |
- |
603 |
| 2026-01-02 |
Zoghbi Huda Y |
Director |
RSU 부여 |
155 |
- |
- |
1,703 |
| 2026-01-02 |
Bassler Bonnie L |
Director |
RSU 부여 |
155 |
- |
- |
1,703 |
| 2026-01-02 |
Guarini Kathryn |
Director |
RSU 부여 |
155 |
- |
- |
603 |
| 2025-12-31 |
Schleifer Leonard S |
Bd. Co-chair, President & CEO |
RSU 원천징수 |
28,570 |
$772.09 |
$22.06M |
214,523 |
| 2025-12-31 |
Yancopoulos George |
Bd. Co-chair, President & CSO |
RSU 원천징수 |
28,570 |
$772.09 |
$22.06M |
310,460 |
| 2025-12-30 |
Sing George L |
Director |
옵션 행사 (매도) |
9,212 |
$520.01 |
$4.79M |
- |
| 2025-12-09 |
Yancopoulos George |
Bd. Co-chair, President & CSO |
RSU 원천징수 |
131,874 |
$701.51 |
$92.51M |
310,460 |
| 2025-12-09 |
Van Plew Daniel P |
EVP & General Mgr, Industrial |
RSU 원천징수 |
2,552 |
$701.51 |
$1.79M |
21,673 |
| 2025-12-09 |
Mccourt Marion |
EVP Commercial |
RSU 원천징수 |
1,021 |
$701.51 |
$716.24K |
14,349 |
| 2025-12-09 |
Murphy Andrew J |
EVP Research |
RSU 원천징수 |
4,229 |
$701.51 |
$2.97M |
47,833 |
| 2025-01-02 |
Sing George L |
Director |
RSU 부여 |
1,958 |
$719.37 |
$1.41M |
1,958 |
| 2025-01-02 |
Brown Michael S |
Director |
RSU 부여 |
166 |
- |
- |
1,548 |
| 2025-01-02 |
Ryan Arthur F |
Director |
RSU 부여 |
1,958 |
$719.37 |
$1.41M |
1,958 |
| 2025-01-02 |
Poon Christine A |
Director |
RSU 부여 |
1,958 |
$719.37 |
$1.41M |
1,958 |
| 2025-01-02 |
Coles N Anthony |
Director |
RSU 부여 |
166 |
- |
- |
1,559 |
| 2025-01-02 |
Goldstein Joseph L |
Director |
RSU 부여 |
1,958 |
$719.37 |
$1.41M |
1,958 |
| 2025-01-02 |
Thompson Craig B. |
Director |
RSU 부여 |
166 |
- |
- |
620 |
| 2025-01-02 |
Schenkein David P |
Director |
RSU 부여 |
166 |
- |
- |
448 |
| 2025-01-02 |
Zoghbi Huda Y |
Director |
RSU 부여 |
166 |
- |
- |
1,548 |
| 2025-01-02 |
Bassler Bonnie L |
Director |
RSU 부여 |
166 |
- |
- |
1,548 |
| 2025-01-02 |
Guarini Kathryn |
Director |
RSU 부여 |
166 |
- |
- |
448 |
| 2024-12-31 |
Sing George L |
Director |
옵션 행사 (매도) |
3,338 |
$413.33 |
$1.38M |
- |
| 2024-12-20 |
Poon Christine A |
Director |
상속 (매수) |
14 |
- |
- |
2,186 |
| 2024-12-16 |
Stahl Neil |
EVP Research and Development |
RSU 원천징수 |
304 |
$730.81 |
$222.17K |
48,829 |
| 2024-12-16 |
Larosa Joseph J |
EVP General Counsel and Secret |
RSU 원천징수 |
702 |
$730.81 |
$513.03K |
30,075 |
| 2024-12-16 |
Van Plew Daniel P |
EVP & General Mgr, Industrial |
RSU 원천징수 |
969 |
$730.81 |
$708.15K |
34,792 |
| 2024-12-16 |
Mccourt Marion |
EVP Commercial |
RSU 원천징수 |
759 |
$730.81 |
$554.68K |
14,230 |
| 2024-12-16 |
Fenimore Christopher R. |
SVP Finance & CFO |
RSU 원천징수 |
491 |
$730.81 |
$358.83K |
16,265 |
| 2024-12-16 |
Murphy Andrew J |
EVP Research |
RSU 원천징수 |
1,054 |
$730.81 |
$770.27K |
49,074 |
| 2024-12-16 |
Pitofsky Jason |
VP Controller |
RSU 원천징수 |
298 |
$730.81 |
$217.78K |
4,664 |
| 2024-12-09 |
Stahl Neil |
EVP Research and Development |
RSU 원천징수 |
466 |
$787.00 |
$366.74K |
49,133 |
| 2024-12-09 |
Larosa Joseph J |
EVP General Counsel and Secret |
RSU 원천징수 |
492 |
$787.00 |
$387.2K |
30,777 |
| 2024-12-09 |
Van Plew Daniel P |
EVP & General Mgr, Industrial |
RSU 원천징수 |
492 |
$787.00 |
$387.2K |
35,761 |
| 2024-12-09 |
Mccourt Marion |
EVP Commercial |
RSU 원천징수 |
274 |
$787.00 |
$215.64K |
14,989 |
| 2024-12-09 |
Fenimore Christopher R. |
SVP Finance & CFO |
RSU 원천징수 |
1,140 |
$787.00 |
$897.18K |
16,756 |
| 2024-12-09 |
Murphy Andrew J |
EVP Research |
RSU 원천징수 |
492 |
$787.00 |
$387.2K |
50,128 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료